Antibacterial; antifungal

Hexetidine-containing mouthwash as a monotherapy or as an adjunct can be used in oral hygiene in the prevention of plaque accumulation and gingival inflammation.[3]

Reduction in the number of colony-forming units of Candida albicans after immersion of the dentures with chlorhexidine digluconate 0.12% was significantly greater than that of the group using hexetidine 0.1% and those of the control group. Hexetidine 0.1% solution tested for the first time as a product of disinfection of the acrylic dentures showed average results after immersion of 8 night hours for 4 days and was less effective than chlorhexidine digluconate 0.12%.[1]

A total of 60 denture wearers (20 men, 40 women; age range 40-80 years) with clinical evidence of DS were randomly divided into 2 test groups and 1 control group. The dentures of each test group were treated by immersion in one of the two mouthwashes while those of the control group were immersed in distilled water. Swab samples from the palatal surfaces of the upper dentures were collected before and after of cleaner use and examined mycologically.[1]

Absorption, Distribution and Excretion
Because heratodin is cationic, it is absorbed by the mucous membranes and dental plaque after oral administration and is difficult to remove. Human studies using radiolabeled heratodin have shown that after a single mouthwash, heratodin can remain on the oral mucosa for 8 to 10 hours, and its presence can be detected in oral tissues for up to 65 hours after administration.

Toxicological Information
Antidote and Emergency Treatment
Immediate First Aid: Ensure adequate decontamination has been performed. If the patient stops breathing, begin artificial respiration immediately, preferably using a machine on demand, bag-valve-mask, or simple breathing mask (if trained). Perform cardiopulmonary resuscitation (CPR) if necessary. Immediately flush contaminated eyes with running water. Do not induce vomiting. If vomiting occurs, tilt the patient forward or place them in the left lateral decubitus position (head down if possible) to maintain an open airway and prevent aspiration. Keep the patient calm and maintain normal body temperature. Seek medical attention. /Class A and Class B Toxins/
Basic Management: Establish an open airway (using an oropharyngeal or nasopharyngeal airway if necessary). Suction if necessary. Observe for signs of respiratory failure and provide assisted ventilation if necessary. Administer oxygen using a non-invasive breathing mask at a flow rate of 10 to 15 liters per minute. Monitor for pulmonary edema and treat as necessary… Monitor for shock and treat as necessary… Predict seizures and treat as necessary… If eyes become contaminated, rinse immediately with water. During transport, continuously rinse eyes with 0.9% normal saline (NS)... Do not use emetics. If swallowed, rinse mouth; if the patient is able to swallow, has a strong gag reflex, and does not drool, administer 5 mL/kg to 200 mL of water to dilute... After cleansing, cover skin burns with a dry, sterile dressing... /Class A and B Poisons/
Advanced Treatment: For patients with impaired consciousness, severe pulmonary edema, or severe respiratory distress, consider oropharyngeal or nasopharyngeal endotracheal intubation to control the airway. Positive pressure ventilation using a bag-valve-mask may be effective. Consider medical treatment for pulmonary edema... For severe bronchospasm, consider the use of β-receptor agonists, such as salbutamol... Monitor heart rhythm and treat arrhythmias if necessary... Initiate intravenous infusion of 5% glucose solution/SRP: "Keep the vessels open," minimum flow rate. If signs of hypovolemia appear, administer 0.9% normal saline (NS) or lactated Ringer's solution. For hypotension accompanied by signs of hypovolemia, administer fluids with caution. Be alert for signs of fluid overdose… Use diazepam or lorazepam to treat seizures… Use promecaine hydrochloride as an adjunct to eye irrigation…

---

Non-human toxicity values: Oral LD50 in rats is 610-1430 mg/kg

[1]. J Int Oral Health. 2015 Aug;7(8):5-8.
[2]. https://en.wikipedia.org/wiki/Hexetidine
[3]. Int J Dent Hyg . 2011 Aug;9(3):182-90. doi: 10.1111/j.1601-5037.2010.00478.x.

1,3-Bis(2-ethylhexyl)-5-methyl-1,3-diazinane-5-amine is an organic nitrogen heterocyclic compound and an organic heteromonocyclic compound. It is a bactericidal and antifungal preservative. It is formulated as a mouthwash at a concentration of 0.1% for the treatment of local infections and oral hygiene. (Excerpt from Martindale Pharmacopoeia, 30th edition, page 797)

C21H45N3

339.6

339.361

C, 74.27; H, 13.36; N, 12.37

141-94-6

3607

Colorless to light yellow liquid

0.9±0.1 g/cm3

388.2±0.0 °C at 760 mmHg

Freezing point = 70 °C

175.0±13.8 °C

0.0±0.8 mmHg at 25°C

1.467

7.15

1

3

12

24

292

0

NC1(C)CN(CC(CC)CCCC)CN(CC(CC)CCCC)C1

DTOUUUZOYKYHEP-UHFFFAOYSA-N

InChI=1S/C21H45N3/c1-6-10-12-19(8-3)14-23-16-21(5,22)17-24(18-23)15-20(9-4)13-11-7-2/h19-20H,6-18,22H2,1-5H3

5-Amino-1,3-bis(2-ethylhexyl)hexahydro-5-methylpyrimidine

NSC 17764; Hexetidine; NSC-17764; Oraldene; Sterisil; Hexoral; Glypesin; Hextril; Elsix; NSC17764

2934.99.03.00

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

DMSO : ~200 mg/mL (~588.93 mM)

Solubility in Formulation 1: ≥ 2.08 mg/mL (6.12 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

---

Solubility in Formulation 2: ≥ 2.08 mg/mL (6.12 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

---

View More

Solubility in Formulation 3: ≥ 2.08 mg/mL (6.12 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

---

 (Please use freshly prepared in vivo formulations for optimal results.)